The Venture Codex Logo

The Venture Codex

Avoro Ventures

110 Greene Street, Suite 800, New York, 10012, United States

Overview

Investment firm managing biopharma venture funds.

Deals ยท 12mo

1

Stage focus

Series B
Series C

Geographic focus

Denmark
United Kingdom
United States

Sector focus

Finance
Financial Exchanges
Financial Services

Investment portfolio

5rounds
NAMEDATESIZE
Hemab
Oct 2025Participated
$157 MSeries C
Vicebio
Sep 2024Participated
$100 MSeries B
Hemab
Feb 2023Participated
$135 MSeries B
Vanqua Bio
Sep 2021Participated
$85 MSeries B
Scribe Therapeutics
Mar 2021Led
$100 MSeries B
Hemab
Oct 2025Participated
$157 MSeries C
Vicebio
Sep 2024Participated
$100 MSeries B
Hemab
Feb 2023Participated
$135 MSeries B
Vanqua Bio
Sep 2021Participated
$85 MSeries B
Scribe Therapeutics
Mar 2021Led
$100 MSeries B
5
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Avoro Ventures: 5 funding rounds are recorded in the selected participation categories.All available history.
Avoro Ventures: 5 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B13
Series C+01

Monthly Deal Activity

Avoro Ventures: 5 deals are recorded across 68 months.All available history.
Avoro Ventures: 5 deals are recorded across 68 months. All available history
MonthDeals
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '231
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Avoro Ventures: Health & Life Sciences is the largest displayed sector by deal count (5 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Avoro Ventures: Health & Life Sciences is the largest displayed sector by deal count (5 deals). All available history
SectorDeals
Health & Life Sciences5

Deal Size Distribution

Avoro Ventures: 5 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Avoro Ventures: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M1
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Avoro Ventures: Europe has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Avoro Ventures: Europe has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
Europe3
United States2
Avoro Ventures: 20 co-investors are shown, with RA Capital Management sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Avoro Ventures: 20 co-investors are shown, with RA Capital Management sharing 3 recorded deals. All available history
Co-investorShared deals
RA Capital Management3
Access Biotechnology2
Deep Track Capital2
HealthCap2
Invus2
Maj Invest2
Novo Holdings2
OrbiMed2
Rock Springs Capital2
Andreessen Horowitz1
Avoro Capital Advisors1
Casdin Capital1
Eli Lilly and Company1
Goldman Sachs1
Logos Capital1
Medicxi1
Menlo Ventures1
Omega Funds1
Osage University Partners1
Perceptive Advisors1

Investment Strategy

Avoro Ventures: Led accounts for 20% and participating for 80% of round participation.All available history.
Avoro Ventures: Led accounts for 20% and participating for 80% of round participation. All available history
CategoryDeals (count)Share (%)
Led120%
Participating480%
Avoro Ventures: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Avoro Ventures: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Behzad Aghazadeh

Managing Partner